Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
12/2005
12/28/2005EP1224183B1 Heterocyclic sodium/proton exchange inhibitors and method
12/28/2005EP1031563B1 Sulfonyl derivatives
12/28/2005EP1000932B9 Aromatic ring derivatives
12/28/2005CN1714082A Process for preparation of imidazolyl compounds
12/28/2005CN1714070A Vitamin d receptor modulators
12/28/2005CN1714060A Method for deuteration or tritiation of heterocyclic ring
12/27/2005US6979694 Drugs such as (5-(((2,4,6-Trimethylphenyl)amino)carbonyl)-4-methyl-2-thiazolyl)carbamic acid, 1,1-dimethylethyl ester, used as enzyme inhibitors, for prohylaxis of inflammatory bowel disease; modulation of immunology
12/27/2005US6979691 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
12/27/2005US6979566 Method of treatment of viral infection including HIV using water soluble fullerenes—III
12/27/2005CA2356325C Topical compositions comprising protected functional thiols
12/27/2005CA2305463C Aminobutanoic acid derivatives
12/27/2005CA2189271C Novel erythromycin derivatives, method for their preparation and their use as drugs
12/22/2005WO2005121101A1 Phenylnaphthylimidazoles for use on copper surfaces during soldering
12/22/2005WO2005121100A1 Melanocortin-4 receptor binding compounds and methods of use thereof
12/22/2005WO2005121073A1 Inhibitors of histone deacetylase
12/22/2005WO2005072082A3 2-guanidinylimidazolidinedione compounds and methods of making and using thereof
12/22/2005US20050282908 Substituted aminopropoxyaryl derivatives useful as agonists for LXR
12/22/2005US20050282907 Benzothiazole or benzothiazine derivative of dipyrido(2,3;b:2',3'-e) diazepin-6-one; viricide against human t-cell leukemia/lymphoma virus
12/22/2005US20050282899 Resorcinol derivatives
12/22/2005US20050282881 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/22/2005US20050282872 Novel thyroid receptor ligands and method II
12/22/2005US20050282805 Five-membered heterocycles useful as serine protease inhibitors
12/22/2005US20050282803 CIS-imidazolines
12/22/2005CA2529445A1 Melanocortin-4 receptor binding compounds and methods of use thereof
12/21/2005EP1606271A1 Insecticidal phthalamide derivatives
12/21/2005EP1606264A1 Monocyclic anilide spirohydantoin cgrp receptor antagonists
12/21/2005EP1606249A2 Compounds, a process for their preparation and their use as dyes and pigments
12/21/2005EP1606244A2 Cycloalkylamides and their therapeutic use as antiepileptic and anticonvulsant
12/21/2005EP1265859B1 Amidino compounds useful as nitric oxide synthase inhibitors
12/21/2005CN1711252A 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders
12/21/2005CN1711247A Celecoxib prodrug
12/21/2005CN1232518C Bi-heterocyclic compounds with antitumour and chemosensitising activity
12/20/2005US6977267 Spiro-hydantoin compounds useful as anti-inflammatory agents
12/20/2005CA2302412C Aminoalkylphenol derivatives and related compounds
12/15/2005WO2005118578A1 Mercaptoimidazoles as ccr2 receptor antagonists
12/15/2005WO2005118575A1 Non nucleoside reverse transcriptase inhibitors
12/15/2005WO2005118574A1 Mercaptoimidazoles as ccr2 receptor antagonists
12/15/2005WO2005118553A1 Tetrasubstituted imidazole derivatives as cannabinoid cb1 receptor modulators with a high cb1/cb2 receptor subtype selectivity
12/15/2005WO2005087751A3 Substituted hydroxyethylamine aspartyl protease inhibitors
12/15/2005US20050277665 e.g. 1,1,1-trifluoro-2-[4-(toluene-2-sulfonyl)phenyl]-propan-2-ol; hydroxysteroid dehydrogenases inhibitor; interconversion between cortisone and cortisol in humans; antidiabetic agent; obesity, insulin resistance, non-insulin -dependent diabetes
12/15/2005US20050277653 Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase
12/15/2005US20050277649 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors; potentiation; diabetes and obesity; 2-(4-{4-[1-(6-chloro-pyridin-3-yl)cyclopropylmethyl]-2-(R)-methyl-piperazine-1-sulfonyl}phenyl)-1,1,1-trifluoro-propan-2-ol
12/15/2005US20050277646 N-[4-({5-(4-fluorophenyl)-4-[4-(trifluoromethyl)phenyl]pyridin-2-yl}oxy)-1,3-benzothiazol-2-yl]acetamide; vanilloid (capsaicin) receptor antagonist/agonist; antiinflammatory, analgesic, antiarthritis, antirheumatic; diseases involving sensory nerve function
12/15/2005US20050277631 Vanilloid receptor ligands and their use in treatments
12/15/2005DE19900094B4 Verfahren zur Herstellung von Lichtschutzzubereitungen, umfassend organische UV-Filter in fester, feinverteilter Form Process for the preparation of sunscreen preparations comprising organic UV filters in solid, finely divided form
12/15/2005CA2566187A1 Mercaptoimidazoles as ccr2 receptor antagonists
12/15/2005CA2565326A1 Tetrasubstituted imidazole derivatives as cannabinoid cb1 receptor modulators with a high cb1/cb2 receptor subtype selectivity
12/15/2005CA2565280A1 Mercaptoimidazoles as ccr2 receptor antagonists
12/14/2005EP1605078A1 Novel imidazole compound and usage thereof
12/14/2005EP1603905A1 Vanilloid receptor ligands and their use in treatments
12/14/2005EP1603902A1 New heterocyclic compounds, a process for their preparation and their use as dyes and pigments
12/14/2005EP1603562A2 Sulfonyl-amidino containing and tetrahydropyrimidino containing compounds as factor xa inhibitors
12/14/2005EP1263712B1 3-(2,5-diaminophenyl)-acrylamide derivatives and colouring agents containing said compounds
12/14/2005EP1224165B1 Novel compounds
12/14/2005EP1223931B1 Use of a imidazole derivative for the treatment or prevention of hypotension and shock
12/14/2005CN1708489A 1-(4-benzyl-piperazin-1-yl)-3-phenyl-propenone derivatives
12/14/2005CN1708480A Carotenoid analogs for the inhibition and amelioration of disease
12/14/2005CN1706832A Tinidazole preparing process
12/14/2005CN1231762C Method for directly identifying candidate compound
12/13/2005US6974829 Succinoyl aminopyrazoles and related compounds
12/13/2005US6974828 3-((2-((3-((Amino(imino)methyl)amino)benzoyl)amino)phenyl)sulf anyl)- 3-(3-pyridinyl)propanoic acid, for example; angiogenic inhibitors; antitumor, -carcinogenic, -metastatic, -diabetic, -arthritic and inflammatory agents; bone disorders
12/13/2005US6974826 such as 3-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)-4-methoxybenzylidene-2,4-thiazolidinedione; Hodgkin's disease
12/13/2005US6974801 Anticancer agents; Alzheimer's diisease; Parkinson's disease; multiple sclerosis; antiinflammatory agents
12/13/2005US6974589 Neutral-cationic lipid for nucleic acid and drug delivery
12/13/2005CA2234066C Substituted imidazoles having anti-cancer and cytokine inhibitory activity
12/08/2005WO2005115991A1 Anti-cytokine heterocyclic compounds
12/08/2005WO2005115990A1 Cinnamide compound
12/08/2005WO2005085196A3 Inhibitors of dna methylation in tumor cells
12/08/2005WO2005075436A3 Novel inhibitors of glutaminyl cyclase
12/08/2005US20050272937 Process for preparing N,N'-carbonyldiazoles
12/08/2005US20050272936 Imidazolium cxcr3 inhibitors
12/08/2005US20050272931 Vanilloid receptor ligands and their use in treatments
12/08/2005US20050272784 Inhibitors of bacterial Type III protein secretion systems
12/08/2005US20050272777 Vanilloid receptor ligands and their use in treatments
12/08/2005US20050272774 Substituted cyclohexane derivatives
12/08/2005US20050272745 Novel piperidine and piperazine derivatives
12/08/2005US20050272710 Providing sustained systemic concentrations of therapeutic or prophylactic agents such as gamma-aminobutyric acid derivatives following oral adiminstration to animals
12/08/2005CA2566094A1 Cinnamide compound
12/08/2005CA2563466A1 Anti-cytokine heterocyclic compounds
12/07/2005EP1602642A1 Imino ether derivative compounds and drugs containing the compounds as the active ingredient
12/07/2005EP1602368A2 Cdc25 phosphatase inhibitors
12/07/2005EP1601460A1 Method for producing bisphenol catalysts and bisphenols
12/07/2005EP1268440B1 Imidazole carbenes
12/07/2005EP1077928B1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
12/07/2005EP1077927B1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
12/07/2005EP0957917B1 Vitronectin receptor antagonists
12/07/2005CN1705646A Hexaarylbiimidazole compounds and photopolymerization initiator compositions containing the same
12/07/2005CN1705640A Ionic liquids containing a sulfonate anion
12/07/2005CN1230425C Optical active compound used as intermediate in preparing optical activity 2-imidazoline-5-thionone derivatives
12/07/2005CN1230416C Pharmaceutical compounds
12/06/2005US6972299 Phenylethynyl and styryl derivatives of imidazole and fused ring heterocycles
12/06/2005US6972297 2-Hydroxy-mutilin carbamate derivatives for antibacterial use
12/06/2005US6972295 Central nervous system disorders; psychological disorders; antiinflammatory agents; multiple sclerosis
12/06/2005US6972287 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits
12/01/2005WO2005113522A1 Azole carboxamide inhibitors of bacterial type iii protein secretion systems
12/01/2005WO2005113513A2 Aryl sulfonamides
12/01/2005WO2005113512A1 Process for the preparation of 1,2-diamines
12/01/2005US20050267190 Solid-state form of celecoxib having enhanced bioavailability
12/01/2005US20050267186 Minimal cardivascular and/or sedatory activity; treating pain and allodynia; selective to alpha2B and/or alpha2C adrenergic receptors in preference over alpha2A adrenergic receptors;
12/01/2005US20050267173 Serine protease inhibitors
1 ... 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 ... 345